Live Chart

O 866.6

H 866.6

L 866.6

VOL 1163

Aurobindo Pharma Overview

Days Range

Low: ₹852.20
High: ₹875.90
Previous Close ₹866.40
Open ₹866.60
Volume 19,13,142
Day’s Range ₹852.20 - ₹875.90
52W Range ₹397.20 - ₹907.70
Market Cap ₹50,748 Cr

Fundamentals of Aurobindo Pharma

ROCE (TTM) 8.56%
P/E Ratio (TTM) 25.66
P/B Ratio 1.89
Industry P/E 31.67
Debt to Equity 0.2
ROE 7.18%
EPS (TTM) 34.44
Dividend Yield 0.87%
Book Value 458
Face Value 1

Financials of Aurobindo Pharma

Sep 2022Dec 2022Mar 2023Jun 2023
Net Sales5,739.376,407.136,472.966,850.52
Profit before tax523.36680.11730.06812.03
Operating Profit410.37491.01505.91569.71
Net Profit410.37491.01505.91569.71
EPS in Rs6.998.388.6410.93

About Aurobindo Pharma

Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. ... Read More

Parent Organisation Indian Private
Founded 1986
Managing Director K Ragunathan

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Torrent Pharmaceuticals Ltd ₹62,653.02


3.25 (-0.18%)

1830 - 1855.5
Lupin Ltd ₹49,938.81


13.10 (1.19%)

1093.85 - 1115
Gland Pharma Ltd ₹27,864.09


33.40 (-1.97%)

1643.2 - 1748
Syngene International Ltd ₹31,027.52


1.40 (-0.18%)

765.05 - 774.9
Alkem Laboratories Ltd ₹42,382.80


5.30 (0.15%)

3512.05 - 3575.65

What's Trending


What is the Share price of Aurobindo Pharma (AUROPHARMA)?

Aurobindo Pharma (AUROPHARMA) share price as of September 25, 2023, on NSE is Rs 873.65 (NSE) and Rs 871.80 (BSE) on BSE.

Can I buy Aurobindo Pharma (AUROPHARMA) shares?

Yes, You can buy Aurobindo Pharma (AUROPHARMA) shares by opening a Demat account with Angel One.

How do I buy Aurobindo Pharma (AUROPHARMA) from Angel One?

Aurobindo Pharma (AUROPHARMA) share can be brought through the following modes:
  1. Direct investment: You can buy Aurobindo Pharma (AUROPHARMA) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Aurobindo Pharma (AUROPHARMA) shares.

Is Aurobindo Pharma a Debt free Company?

No, Aurobindo Pharma is not a debt free company.

What is the main business of Aurobindo Pharma?

The main business of Aurobindo Pharma is to manufacture semi-synthetic penicillin (SSP) through over 27 manufacturing and packaging facilities situated globally. It also has a presence in several therapeutic segments, including neurosciences, gastroenterology, cardiovascular, anti-diabetics, anti-retrovirals, and anti-biotics

Who are the promoters of Aurobindo Pharma?

Some of the promoters of Aurobindo Pharma include Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding), K Nityananda Reddy, Kirthi Reddy Kambam, Venkata Ramprasad Reddy Penaka, and Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd (Jointly Holding).

What are the Subsidiaries that comes under Aurobindo Pharma?

Some of the subsidiaries that come under Aurobindo Pharma are APL Pharma Thai Limited, All Pharma (Shanghai) Trading Company Limited, Aurobindo Pharma USA Inc., Aurobindo Pharma Industria Farmaceutica Ltda, Brazil, Helix Healthcare B.V., The Netherlands, Auro Pharma Inc., Canada, and APL Healthcare Limited.